Log In
BCIQ
Print this Print this
 

PT1403

  Manage Alerts
Collapse Summary General Information
Company Peloton Therapeutics Inc.
Description 
Molecular Target Acyl-CoA synthetase short-chain family member 2 (ACSS2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today